Osteovantiv
Natural health product licensed in Canada
- Licence holder
- Metagenics Inc.
- NPN or DIN-HM
- 80071711
- Status
- Active licence
- Licence date
- 4 August 2016
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Humulus lupulus Source : Strobiles Extract : Matériel brut sec Extraction ratio : 7:1 Dry plant equivalent : 2.8 Grammes | 400 milligramme | Not calculated |
| Gallus gallus Source : Cartilage Potency : 0.6 milligramme Unhydrolyzed collagen type II | 13.6 milligramme | Not calculated |
Non-medicinal ingredients
Hydroxypropylcellulose, Silice, Silicate de calcium, Hypromellose, Triglycérides à chaîne moyenne, Cellulose, Croscarmellose de sodium, Acide stéarique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Comprimé | 2 Tous les jours |
Uses authorised in Canada
Helps to relieve joint pain associated with osteoarthritis of the knee.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use if you are pregnant or breastfeeding.
- Effets indésirables connus
Some people may experience drowsiness. Exercise caution if operating heavy machinery, driving a motor vehicle or involved in activities requiring mental alertness. May cause gastrointestinal symptoms, including abdominal pain, epigastric discomfort, nausea, vomiting, and dizziness.
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are taking prescription medication, if you have a serious medical condition, if you have depression and/or related diseases, if you have rheumatoid arthritis, if you have liver disorder or develop symptoms of liver trouble, or if symptoms persist or worsen. Consumption of hops with alcohol, other medications and/or natural health products with sedative properties is not recommended.
Source
Official Health Canada record, licence 80071711
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.